The mechanism of myoma growth inhibition by GnRH analogs is mediated by hypoestrogenic induction, suppression of proliferation (decrease in Ki‐67 expression), increased apoptosis of myoma cells, and significant reduction in expression of all main growth factors and their receptors.24, 25. The gene discussed is GNRH1; the disease is benign muscle neoplasm.